Details for New Drug Application (NDA): 215875
✉ Email this page to a colleague
The generic ingredient in ADRENALIN is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 215875
Tradename: | ADRENALIN |
Applicant: | Par Sterile Products |
Ingredient: | epinephrine |
Patents: | 3 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 215875
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 2MG/250ML (8MCG/ML) | ||||
Approval Date: | Apr 21, 2023 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Mar 21, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Try a Trial | Patent Expiration: | Mar 21, 2039 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TO INCREASE MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Mar 21, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription